MUMBAI/NEW DELHI, March 29 -- Dr. Reddy's Laboratories will have 30 days to sell existing stock of its semaglutide drug branded "Olymviq" before discontinuing the name, after the Delhi High Court reco... Read More
MUMBAI/NEW DELHI, March 25 -- As semaglutide, the drug behind weight-loss drug Ozempic, goes off-patent in India and cheaper copies flood the market, Novo Nordisk has moved to defend its flagship bran... Read More
MUMBAI/NEW DELHI, March 25 -- As semaglutide, the drug behind weight-loss drug Ozempic, goes off-patent in India and cheaper copies flood the market, Novo Nordisk has moved to defend its flagship bran... Read More